Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 100Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 17Leukemia, Monocytic, Acute 14Leukemia, Myelomonocytic, Acute 13Leukemia, Erythroblastic, Acute 12Leukemia, Megakaryoblastic, Acute 11Congenital Abnormalities 11Leukemia, Promyelocytic, Acute 9Recurrence 8Leukemia, Biphenotypic, Acute 7Carcinoma, Hepatocellular 7Leukemia, Myelomonocytic, Chronic 6Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Anemia, Refractory, with Excess of Blasts 5Lymphoma 4Blast Crisis 4Neoplasm, Residual 3Lymphoma, Large B-Cell, Diffuse 3Liver Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lung Neoplasms 2

Interventions

Daunorubicin 2Cytarabine 2prednylidene 1Vincristine 1Prednisolone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Hydrocortisone 1Etoposide 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Down Syndrome × Idarubicin × Clear all
NCT07232134 2025-11-20

AML-DS-2025

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting
100 enrolled
Other hematologic neoplasm

Down Syndrome, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡